Jeffrey M. Cohen MD
Director, Psoriasis Treatment Program; Assistant Professor of Dermatology, Yale School of Medicine, New Haven, ConnecticutJeffrey M. Cohen, MD, is the Director of the Psoriasis Treatment Program at the Yale School of Medicine, where he serves as an Assistant Professor of Dermatology and Biomedical Informatics and Data Science. His clinical practice focuses on inflammatory skin diseases such as psoriasis and eczema. In his research, Dr. Cohen studies the epidemiology of inflammatory skin disease and also participates in translational research to better understand the immunological underpinnings of psoriasis, eczema, and other skin disorders. Dr. Cohen is a member of the Medical Board of the National Psoriasis Foundation and is a Councilor of the International Psoriasis Council. Dr. Cohen is a graduate of Harvard Medical School, completed an internship in Internal Medicine at Beth Israel Deaconess Medical Center, and a residency in Dermatology at the New York University School of Medicine.
Disclosures
Jeffrey M. Cohen, MD, serves as an editor for Visual Dx, serves on a data and safety monitoring board (DSMB) for Advarra, and has served as a consultant for Novartis and Takeda.Recent Contributions to PracticeUpdate:
- Role of Systemic Inflammation as a Mediator of the Association Between Skin Disease Severity and Cardiovascular Disease in Patients With Psoriasis
- Assessing the Clinical Similarity of SB17 — a Proposed Ustekinumab Biosimilar — to Reference Ustekinumab in Patients With Moderate to Severe Plaque Psoriasis
- Comparative Analysis of Switching Strategies for IL-23 and IL-17A Inhibitor Treatment in Patients With Psoriasis